Skip to main content
. Author manuscript; available in PMC: 2012 Aug 27.
Published in final edited form as: Ann Rheum Dis. 2012 Jan 20;71(7):1157–1162. doi: 10.1136/annrheumdis-2011-200493

Figure 1.

Figure 1

HDL-mediated cholesterol efflux and plasma MPO activity in RA patients with DAS28<2.6 (low disease activity/clinical remission) compared to RA patients with DAS28>5.1 (high disease activity).